U.S. federal trademark · Serial No. 75545841
Pharmaceutical products, namely intravenously administered recombinant- protein, alone or in association with unilamellar vessicles to promote lipid transport in the treatment of atherosclerosis and its associated complications
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.